Take-home messages

ACEF: Age-creatinine-ejection fraction; AF: Atrial fibrillation; AKI: Acute kidney injury; CABG: Coronary artery bypass graft; COPD: Chronic obstructive pulmonary disease; EF:

ACS: Acute coronary syndrome; AF: Atrial fibrillation; CAD: Coronary artery disease; CKD: Chronic kidney disease; DAPT: Dual antiplatelet therapy; eGFR: estimated glomerular

In a single-center cohort of 2973 patients with no previous history of kidney disease who were discharged from the hospital after cardiothoracic surgery, acute kidney injury (AKI)

18 years; (2) absence of acute kidney injury or ongoing recovery from acute kidney injury; (3) no history of chronic renal failure; (4) absence of any condition known to modify

Acute kidney injury risk associated with piperacillin/tazobactam com- pared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline

ABC = Arterial Based Complexity; AKI = acute kidney injury; C-index = Centrality Index; CKD = chronic kidney disease; CS = collecting system; CSA = Contact Surface Area; DAP

AKI: Acute kidney injury; BUN: Blood urea nitrogen; CKD: Chronic kidney disease; EVs: Extracellular vesicles; Gl-MSCs: Resident population of MSCs within glomeruli;

aristolochic acid nephropathy; AKI, acute kidney injury; BEN, Balkan endemic nephropathy; BUN, Blood urea nitrogen; CHN, Chinese herbal nephropathy; CKD, chronic kidney disease;